Company Filing History:
1 out of 1 
1 out of 13 
Years Active: 2007
Title: The Innovations of Erica Van Oort
Introduction
Erica Van Oort is a notable inventor based in Vleuten, Netherlands. She has made significant contributions to the field of biotechnology, particularly in the area of allergen research. Her work has led to the development of a patented nucleic acid molecule that has implications for allergy treatment.
Latest Patents
Erica holds 1 patent for a purified nucleic acid molecule comprising a nucleotide sequence coding for allergen Dac g5, which has the amino acid sequence SEQ ID NO. 2, along with its derivatives or fragments. This innovation represents a step forward in understanding and potentially mitigating allergic reactions.
Career Highlights
Throughout her career, Erica has worked with prominent companies in the biotechnology sector. She has been associated with Seita Groupe Altadis and Stallergenes, where she has applied her expertise in allergen research and development. Her contributions have been instrumental in advancing the understanding of allergens and their effects on human health.
Collaborations
Erica has collaborated with esteemed colleagues in her field, including Ronald Van Ree and Caroline Bonneau. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of knowledge.
Conclusion
Erica Van Oort's work exemplifies the impact of innovative research in biotechnology. Her patented inventions and collaborations highlight her commitment to advancing the field of allergen research.